Compositions which are suitable for employment as antidotes to blood anticoagulants, and their use
WO9907744A1
Polysaccharide conjugates of biomolecules
WO9803877A1
Reagents for assays for ligands
CA2217143A1
Positive controls for use in polynucleotide amplification
AU1565397A
Detection of differences in nucleic acids
MX9606585A
Human mucin (muc8).
MX9606583A
Determination immunological method.
DE19634313A1
Method for stabilizing platelets
DE19634312A1
Process for producing factor V deficient plasma and a deficient plasma obtained in this way
DE19629444A1
Increased sensitivity in the immunochemical determination of an analyte
EP0759556A2
Method for quantification of activated factors
AU5276296A
Medicament containing at least one part of the ul84 protein of the cytomegalovirus, use of polypeptides corresponding to the amino acid sequence of the ul84 protein, and process for introducing ul84 into target cells
AU5276196A
Method for the continuous preparation of recombinant proteinsfrom cell cultures
DE19612967A1
Process for the propagation of influenza viruses in cell culture, and the influenza viruses obtainable by the process
ZA9602074B
Method of treating acute mycocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
NZ286082A
Method of treating acute myocardial infarction with hirudin and acetylsalicylic acid in patients not undergoing thrombolytic treatment
DE19607239A1
Pharmaceutical composition containing hirudin and process for its preparation
CN1180376A
Cell line and process for multiplying rabies viruses and their quantitative detection
